Naeye, Thierry,Einerhand, Alexandra,Lopez, Michel,Potter, Susan M.,Remaud-Simeon, Magali,Monsan, Pierre Frederic Emmanuel
申请号：
AU2010245761
公开号：
AU2010245761B2
申请日:
2010.05.07
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
Compositions for improving the health of a subject comprise alpha-(l,2)- branched alpha-(l,6) oligodextrans, preferably with an average molecular weight between about 10 kDa and 70 kDa, between about 10% and 50% alpha-(l,2)-osidic side chains, and having at least partial indigestibility in the subject. Methods for improving the health of a subject comprise administering the composition to a subject in an amount effective to improve gut health, or to prevent or treat a gastrointestinal disorder, a cholesterol-related disorder, diabetes, or obesity. Methods for making oligodextrans having controlled size and controlled degree of branching comprise providing alpha-(l,6) oligodextrans having an average molecular weight between 0.5 and 100 kDa and introducing at least 10% alpha-(l,2)-osidic side chains onto the alpha-(l,6) oligodextrans.
